These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 15707475

  • 1. Etanercept in arthritis.
    Scott DL.
    Int J Clin Pract; 2005 Jan; 59(1):114-8. PubMed ID: 15707475
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Tijhuis GJ, van de Putte LB, Breedveld FC.
    Ned Tijdschr Geneeskd; 2001 Sep 29; 145(39):1880-5. PubMed ID: 11605312
    [Abstract] [Full Text] [Related]

  • 3. Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein.
    Zhou H.
    J Clin Pharmacol; 2005 May 29; 45(5):490-7. PubMed ID: 15831771
    [Abstract] [Full Text] [Related]

  • 4. Etanercept Immunex.
    Yung RL.
    Curr Opin Investig Drugs; 2001 Feb 29; 2(2):216-21. PubMed ID: 11816834
    [Abstract] [Full Text] [Related]

  • 5. Treatment of rheumatoid arthritis with etanercept.
    Genovese MC, Kremer JM.
    Rheum Dis Clin North Am; 2004 May 29; 30(2):311-28, vi-vii. PubMed ID: 15172043
    [Abstract] [Full Text] [Related]

  • 6. Etanercept: new preparation. Useful after methotrexate failure in inflammatory rheumatism.
    Prescrire Int; 2003 Aug 29; 12(66):127-32. PubMed ID: 12906020
    [Abstract] [Full Text] [Related]

  • 7. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis.
    Bliddal H, Terslev L, Qvistgaard E, Konig M, Holm CC, Rogind H, Boesen M, Danneskiold-Samsøe B, Torp-Pedersen S.
    Scand J Rheumatol; 2006 Aug 29; 35(5):341-5. PubMed ID: 17062431
    [Abstract] [Full Text] [Related]

  • 8. Etanercept: new indication. For ankylosing spondylitis: another option.
    Prescrire Int; 2005 Jun 29; 14(77):92-3. PubMed ID: 15981387
    [Abstract] [Full Text] [Related]

  • 9. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
    van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ, Etanercept Study 400 Investigators.
    Ann Rheum Dis; 2008 Feb 29; 67(2):182-8. PubMed ID: 17728331
    [Abstract] [Full Text] [Related]

  • 10. Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis.
    Goldenberg MM.
    Clin Ther; 1999 Jan 29; 21(1):75-87; discussion 1-2. PubMed ID: 10090426
    [Abstract] [Full Text] [Related]

  • 11. Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.
    Brandt J, Listing J, Haibel H, Sörensen H, Schwebig A, Rudwaleit M, Sieper J, Braun J.
    Rheumatology (Oxford); 2005 Mar 29; 44(3):342-8. PubMed ID: 15561737
    [Abstract] [Full Text] [Related]

  • 12. Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis.
    Bansback NJ, Ara R, Barkham N, Brennan A, Fraser AD, Conway P, Reynolds A, Emery P.
    Rheumatology (Oxford); 2006 Aug 29; 45(8):1029-38. PubMed ID: 16782734
    [Abstract] [Full Text] [Related]

  • 13. Etanercept for the treatment of psoriasis: combination therapy with other modalities.
    Strober BE, Clarke S.
    J Drugs Dermatol; 2004 Aug 29; 3(3):270-2. PubMed ID: 15176161
    [Abstract] [Full Text] [Related]

  • 14. Post-approval trials of new medicines: widening use or deepening knowledge? Analysis of 10 years of etanercept.
    van Luijn JC, Danz M, Bijlsma JW, Gribnau FW, Leufkens HG.
    Scand J Rheumatol; 2011 May 29; 40(3):183-91. PubMed ID: 20858147
    [Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor inhibitors: new options for treating rheumatoid arthritis.
    Moreland LW.
    Isr Med Assoc J; 2001 Sep 29; 3(9):686-90. PubMed ID: 11574988
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.
    Bathon JM, Fleischmann RM, Van der Heijde D, Tesser JR, Peloso PM, Chon Y, White B.
    J Rheumatol; 2006 Feb 29; 33(2):234-43. PubMed ID: 16465653
    [Abstract] [Full Text] [Related]

  • 17. Etanercept (Enbrel) -- an update.
    Goffe B.
    Skin Therapy Lett; 2006 Feb 29; 9(10):1-4, 9. PubMed ID: 15657632
    [Abstract] [Full Text] [Related]

  • 18. Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis.
    Boonen A, van der Heijde D, Severens JL, Boendermaker A, Landewé R, Braun J, Brandt J, Sieper J, van der Linden S.
    Ann Rheum Dis; 2006 Feb 29; 65(2):201-8. PubMed ID: 16014677
    [Abstract] [Full Text] [Related]

  • 19. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR, Keating GM.
    Drugs; 2002 Feb 29; 62(17):2493-537. PubMed ID: 12421111
    [Abstract] [Full Text] [Related]

  • 20. Etanercept. Immunex.
    Pugsley MK.
    Curr Opin Investig Drugs; 2001 Dec 29; 2(12):1725-31. PubMed ID: 11892935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.